Spatial Biology – News and Features

News
VentiRx Pharmaceuticals Publishes Preclinical Data of Novel TLR8 Agonist
The data collected on VTX-2337 supports its potential as an immunotherapeutic approach in cancer. The preclinical data published in Clinical Cancer Research also underscores important differences between TLRs in human immune responses.

News
Thermo Scientific Presents $35,000 Distinguished Research Award to Dr. Judit Villen, University of Washington
Innovative research begins new era of mass spectrometry-based single-cell measurements to enhance understanding of the growth, proliferation and differentiation of cells.

News
Metamark Genetics Partners with Definiens on Tissue-Based Cancer Diagnostics
Partnership forged to tackle tumor heterogeneity.

News
System Integration - A Major Step Toward Lab on a Chip
In this article researchers from the University of Arizona review several promising system integration approaches for microfluidics and discuss their advantages, limitations and applications.

News
IntelliCyt Corporation Announces Partnership with European Distributors
Delivers exclusive distribution rights for IntelliCyt's full line of instrumentation, informatics software, and assay kit products.

News
RainDance Technologies Names Andy Watson Vice President and Chief Marketing Officer
In this role, Mr. Watson will lead the company’s global marketing and strategy efforts to grow the current commercial targeted sequencing business and prepare the market for the launch of its digital PCR and single cell analysis products.

News
Fluidigm Reports Financial Results for First Quarter 2011
Total revenue for the first quarter of 2011 was $8.7 million, an increase of 30% from $6.7 million in the first quarter of 2010.

News
Biophysicist Targeting IL-6 to Halt Breast, Prostate Cancer
OSU’s Li disrupts cellular messages through fragment-based drug design.

News
NIH Study Identifies Gene that Suppresses Cell's Immune Activation
FOXO3 gene suppresses activation of cells related to immunity and thus leads to a reduced immune response against a growing cancer.

News
NIH Study Identifies Gene that Suppresses Cell’s Immune Activation
A new study of prostate tumors has shown that a gene, FOXO3, suppresses activation of cells related to immunity and thus leads to a reduced immune response against a growing cancer.
Advertisement